Who is behind IBDUnited
Dr. Feza Remzi spearheads
A board of directors including Dr. Stephen Hanauer, Brian Feagan provide additional input in regards to the needs of the health care providers.
As a colorectal surgeon at NYU Langone, Dr. Remzi is an expert in the surgical management of inflammatory bowel disease, also known as Crohn’s disease and ulcerative colitis. He performs pelvic pouch surgery and complex abdominopelvic reoperative IBD surgery.
Dr. Remzi serves as the director of the Inflammatory Bowel Disease Center, and he is one of the few colorectal surgeons in the world who is specialized in caring for people who are experiencing problems with prior pelvic pouch, or J-pouch, complex reoperative
IBD procedures as one of the few surgeons and centers as a last resort. He has been practicing in the field of colorectal surgery for more than 20 years. His team consists of medical, surgical, and nursing professionals who devoted all of their efforts to giving patients a better chance at life.
As a world-renowned expert in the field of IBD, Dr. Remzi has published many articles and book chapters on the surgical management of inflammatory bowel disease, ileal J-pouch surgery, and reoperative abdominopelvic surgery.
Managing patients with inflammatory bowel disease (IBD) is medically and surgically complex. Multiple patient-related and disease-oriented factors need to be considered, for example, nutritional support, the effects of immunosuppressive agents and/or biologicals, extent of resection, and use of proximal diversion. While new therapies have helped decrease hospital admission rates, incidence rates for surgery remain high. The risk of surgery in patients with Crohn’s disease is approximately 50% at a 10-year disease duration, while 40% of patients with ulcerative colitis requiring inpatient care will ultimately require proctocolectomy. Postoperative endoscopic recurrence of CD is near 90% at one year. In ulcerative colitis, a disease that has historically been considered curative with surgery, significant rates of postoperative transition to CD, difficult to control pouchitis, and systemic inflammatory manifestations point out that the disease has an immunologic basis that persists even after proctocolectomy